Guido Guidi
Director/Board Member at GENENTA SCIENCE S.P.A.
Net worth: 225 887 $ as of 2024-03-30
Profile
Guido Guidi is the founder of Aurora Science Srl, Aurora Tt SRL.
He currently holds the position of Vice Chairman at Recordati SpA, Chairman at Cellestia Biotech AG, Director at Philogen SpA, Director at Zambon SpA, Director at Tethis SpA, Independent Director at Genenta Science SpA, Managing Director at Geleven SRL, and Member at Italfarmaco SpA.
In the past, he served as Chairman at Novartis UK Ltd., Novartis Farmacéutica SA, and Novartis Norge AS.
He was also the Medical Director at Sharper Italia from 1986 to 1989, Head-Immunology & Transplantation at Sandoz SpA from 1992 to 2000, and Head-Oncology at Elanco Italia SpA from 2000 to 2012.
Dr. Guidi obtained his undergraduate degree from the University of Milan in 1979.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENENTA SCIENCE SPA
0.35% | 2023-04-18 | 64,539 ( 0.35% ) | 225 887 $ | 2024-03-30 |
Guido Guidi active positions
| Companies | Position | Start |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Director/Board Member | 2016-12-31 |
| PHILOGEN S.P.A. | Director/Board Member | 2019-05-12 |
| RECORDATI | Director/Board Member | 2020-04-28 |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Chairman | - |
| Geleven SRL | Chief Executive Officer | - |
Aurora Science Srl
 Aurora Science Srl Investment ManagersFinance Aurora Science, invests in Italian startups. The fund invests in health technology with particular interest for biotech and pharmaceuticals. It provides equity financing for early stage investing between EUR 1 to EUR 5 million. | Founder | - |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Director/Board Member | - |
Zambon SpA
 Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Director/Board Member | - |
Italfarmaco SpA
 Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Corporate Officer/Principal | - |
| ░░░░░░ ░░ ░░░ | ░░░░░░░ | - |
Former positions of Guido Guidi
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
Training of Guido Guidi
| University of Milan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| RECORDATI | Health Technology |
| PHILOGEN S.P.A. | Health Technology |
| GENENTA SCIENCE S.P.A. | Health Technology |
| Private companies | 13 |
|---|---|
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Health Technology |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Health Technology |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
| Novartis Farmacéutica SA | |
Sandoz SpA
 Sandoz SpA Pharmaceuticals: MajorHealth Technology Sandoz SpA manufactures pharmaceutical products. It develops and distributes medicines for cardiovascular systems, antibiotics, antidepressants, anti-asthmatics, calcium compounds, and laxatives. The company is headquartered in Origgio, Italy. | Health Technology |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Health Technology |
Novartis Norge AS
 Novartis Norge AS Miscellaneous Commercial ServicesCommercial Services Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway. | Commercial Services |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Health Technology |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Aurora Science Srl
Aurora Science Srl Investment ManagersFinance Aurora Science, invests in Italian startups. The fund invests in health technology with particular interest for biotech and pharmaceuticals. It provides equity financing for early stage investing between EUR 1 to EUR 5 million. | Finance |
| Sharper Italia | |
| Geleven SRL | |
| Aurora Tt SRL |
- Stock Market
- Insiders
- Guido Guidi
